SB17170 Phase 2 Trial in IPF Patients
SB17170 Phase 2 Trial in IPF Patients
Recruiting · NCT06747923 · Registry updated 2025-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SB17170 Phase 2 Trial in IPF Patients | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2025-11-19 | NCT06747923 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SPARK Biopharma | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ajou University Hospital | Suwon | South Korea | 31 |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong | South Korea | 14 |
| Myong Ji Hospital | Goyang | South Korea | 1 |
| Seoul Asan Hospital | Seoul | South Korea | 2 |
| The Catholic Univ. of Korea Seoul St. Mary's hospital | Seoul | South Korea | 3 |